Tuunanen, I.; Hautakoski, A.; Huhtamäki, H.; Arffman, M.; Sund, R.; Puistola, U.; Karihtala, P.; Jukkola, A.; Urpilainen, E.
The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Biomedicines 2024, 12, 1654.
https://doi.org/10.3390/biomedicines12081654
AMA Style
Tuunanen I, Hautakoski A, Huhtamäki H, Arffman M, Sund R, Puistola U, Karihtala P, Jukkola A, Urpilainen E.
The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Biomedicines. 2024; 12(8):1654.
https://doi.org/10.3390/biomedicines12081654
Chicago/Turabian Style
Tuunanen, Iida, Ari Hautakoski, Heikki Huhtamäki, Martti Arffman, Reijo Sund, Ulla Puistola, Peeter Karihtala, Arja Jukkola, and Elina Urpilainen.
2024. "The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study" Biomedicines 12, no. 8: 1654.
https://doi.org/10.3390/biomedicines12081654
APA Style
Tuunanen, I., Hautakoski, A., Huhtamäki, H., Arffman, M., Sund, R., Puistola, U., Karihtala, P., Jukkola, A., & Urpilainen, E.
(2024). The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Biomedicines, 12(8), 1654.
https://doi.org/10.3390/biomedicines12081654
